Issue #5 2015 – Digital edition

Posted: 22 October 2015 |

In Issue #5 2015: Counterfeit Drugs, Regulatory Insight, Raman In-Depth Focus, PAT Series, Polymorphs, RMM In-Depth Focus, Particle Sizing, Freeze Drying, and much more…

European Pharmaceutical Review - Issue 5 2015
  • FOREWORD: The importance of good distribution practice
    David Elder, GlaxoSmithKline and JPAG
  • COUNTERFEIT DRUGS: Counterfeit medicines and the need for a global approach
    David Shore, Pfizer
  • REGULATORY INSIGHT: New third-party audit scheme for excipient suppliers
    Iain Moore, President, EXCiPACT asbl
    Featuring articles from Sulaf Assi, Bournemouth University, Sulayman A. Oladepo, Hui Wang, David Barona and Reinhard Vehring, University of Alberta
  • PAT SERIES: Continuous manufacturing in pharma – an unstoppable trend?
    Bernhard Gutmann and Christian Oliver Kappe, University of Graz
  • POLYMORPHS: Promiscuous multicomponent drug crystals
    Masataka Ito, Kiyohiko Sugano and Katsuhide Terada, Faculty of Pharmaceutical Sciences, Toho University
    Featuring articles from David Roesti and Erik Wilkens, Novartis, Mostafa Eissa, Hikma Pharmaceuticals, and Hideharu Shintani, Chuo University
  • PARTICLE SIZING: Meeting biopharmaceutical analytical requirements for subvisible particle sizing and counting
    John Carpenter, University of Colorado, Amber Haynes Fradkin, KBI Biopharma, and Christina Vessely, Biologics Consulting Group Inc.
  • FREEZE DRYING: Dynamic vapour sorption of freeze-dried pharmaceuticals
    Claudia Kunz & Henning Gieseler, University of Erlangen

Issue #5 2015 is restricted to logged-in members. Login or subscribe free to read it.

Send this to a friend